Bontempo Ohly Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-52,595
| Closed | -$2.36M | – | 34 |
|
|
2024
Q4 | $2.36M | Buy |
52,595
+932
| +2% | +$52.3K | 1.15% | 23 |
|
|
2024
Q3 | $3.25M | Buy |
51,663
+1,279
| +3% | +$74.6K | 1.48% | 23 |
|
|
2024
Q2 | $2.98M | Buy |
50,384
+874
| +2% | +$54.7K | 1.49% | 22 |
|
|
2024
Q1 | $3.95M | Buy |
49,510
+6,107
| +14% | +$466K | 1.93% | 20 |
|
|
2023
Q4 | $3.43M | Buy |
43,403
+2,055
| +5% | +$146K | 1.66% | 19 |
|
|
2023
Q3 | $2.89M | Sell |
41,348
-3,013
| -7% | -$213K | 1.58% | 21 |
|
|
2023
Q2 | $3.07M | Buy |
44,361
+374
| +0.9% | +$26.6K | 1.49% | 21 |
|
|
2023
Q1 | $3.27M | Buy |
43,987
+6,669
| +18% | +$559K | 1.63% | 22 |
|
|
2022
Q4 | $3.48M | Sell |
37,318
-187
| -0.5% | -$18K | 2.07% | 14 |
|
|
2022
Q3 | $3.58M | Buy |
37,505
+434
| +1% | +$43K | 2.37% | 11 |
|
|
2022
Q2 | $3.44M | Buy |
37,071
+39
| +0.1% | +$3.81K | 2.12% | 14 |
|
|
2022
Q1 | $3.75M | Sell |
37,032
-7,450
| -17% | -$783K | 2.06% | 17 |
|
|
2021
Q4 | $4.59M | Buy |
44,482
+740
| +2% | +$68.4K | 2.37% | 6 |
|
|
2021
Q3 | $3.71M | Sell |
43,742
-420
| -1% | -$35.2K | 2.08% | 11 |
|
|
2021
Q2 | $3.69M | Sell |
44,162
-519
| -1% | -$42.5K | 2% | 17 |
|
|
2021
Q1 | $3.36M | Buy |
44,681
+1,054
| +2% | +$76.8K | 1.88% | 23 |
|
|
2020
Q4 | $2.98M | Buy |
43,627
+1,280
| +3% | +$83.3K | 1.79% | 19 |
|
|
2020
Q3 | $2.47M | Buy |
42,347
+935
| +2% | +$58.2K | 1.68% | 21 |
|
|
2020
Q2 | $2.69M | Buy |
41,412
+683
| +2% | +$43K | 1.9% | 15 |
|
|
2020
Q1 | $2.42M | Buy |
40,729
+2,605
| +7% | +$174K | 2.01% | 14 |
|
|
2019
Q4 | $2.83M | Buy |
38,124
+715
| +2% | +$50.2K | 1.89% | 19 |
|
|
2019
Q3 | $2.36M | Buy |
37,409
+405
| +1% | +$24K | 1.68% | 24 |
|
|
2019
Q2 | $2.02M | Buy |
37,004
+725
| +2% | +$39K | 1.46% | 26 |
|
|
2019
Q1 | $1.96M | Sell |
36,279
-839
| -2% | -$51.8K | 1.42% | 26 |
|
|
2018
Q4 | $2.43M | Buy |
37,118
+594
| +2% | +$44.3K | 1.8% | 16 |
|
|
2018
Q3 | $2.88M | Buy |
36,524
+4,649
| +15% | +$332K | 1.92% | 17 |
|
|
2018
Q2 | $2.05M | Buy |
31,875
+672
| +2% | +$44.3K | 1.61% | 24 |
|
|
2018
Q1 | $1.94M | Sell |
31,203
-200
| -0.6% | -$14.3K | 1.55% | 23 |
|
|
2017
Q4 | $2.2M | Buy |
31,403
+9,593
| +44% | +$697K | 1.72% | 21 |
|
|
2017
Q3 | $1.77M | Sell |
21,810
-20
| -0.1% | -$1.58K | 1.37% | 23 |
|
|
2017
Q2 | $1.76M | Buy |
21,830
+109
| +0.5% | +$8.61K | 1.42% | 25 |
|
|
2017
Q1 | $1.71M | Buy |
+21,721
| New | +$1.73M | 1.37% | 28 |
|
Other funds holding CVS
Bontempo Ohly Capital Management's CVS Position: Q1 2025 in Review
Bontempo Ohly Capital Management sold out of CVS Health (CVS) in Q1 2025, closing a stake of 52,595 shares — an estimated $2.36M sold.
Bontempo Ohly Capital Management first reported a position in CVS in Q1 2017 and held it in 32 quarters. The position peaked at $4.59M in Q4 2021. 1,753 funds tracked by Wall St. Rank hold CVS as of Q1 2025.
- Bontempo Ohly Capital Management reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
- Bontempo Ohly Capital Management sold 52,595 CVS Health shares in Q1 2025, an estimated $2.36M.
- Bontempo Ohly Capital Management first reported a position in CVS Health in Q1 2017 and held it in 32 quarters.
- Bontempo Ohly Capital Management's CVS Health position peaked at $4.59M in Q4 2021.
- 1,753 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.
Based on Bontempo Ohly Capital Management's 13F filing for Q1 2025, filed 6 Jun 2025.